Advertisement

Browse Subject Areas

?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

Immunotherapy

A three-dimensional immune-oncology model for studying in vitro primary human NK cell cytotoxic activity

Nontaphat Thongsin, Methichit Wattanapanitch

Myasthenia gravis complement activity is independent of autoantibody titer and disease severity

Miriam L. Fichtner, Michelle D. Hoarty, [ ... ], Kevin C. O’Connor

Survival of immature pre-adult Gnathostoma spinigerum in humans after treatment with albendazole

Tapanee Kanjanapruthipong, Sumate Ampawong, [ ... ], Dorn Watthanakulpanich

Correlation analysis of m⁶A-modified regulators with immune microenvironment infiltrating cells in lung adenocarcinoma

Wei Ye, Tianpeng Huang

Programme death ligand 1 expressions as a surrogate for determining immunotherapy in cervical carcinoma patients

Sebastian A. Omenai, Mustapha A. Ajani, Clement A. Okolo

Predictive value of tumor mutational burden for immunotherapy in non-small cell lung cancer: A systematic review and meta-analysis

Guangxian Meng, Xiaowei Liu, [ ... ], Ge Sun

Nicotine treatment regulates PD-L1 and PD-L2 expression via inhibition of Akt pathway in HER2-type breast cancer cells

Masanori A. Murayama, Erika Takada, [ ... ], Noboru Suzuki

Clinical efficacy of nivolumab is associated with tertiary lymphoid structures in surgically resected primary tumors of recurrent gastric cancer

Takuya Mori, Hiroaki Tanaka, [ ... ], Masaichi Ohira

Combined mRNAs and clinical factors model on predicting prognosis in patients with triple-negative breast cancer

Yanjun Hu, Dehong Zou

Reduced production of the major allergens Bla g 1 and Bla g 2 in Blattella germanica after antibiotic treatment

Seogwon Lee, Ju Yeong Kim, [ ... ], Tai-Soon Yong

Prospective observational study of nutritional/immunologic indices as predictive biomarkers for the response to anti-PD-1 drugs in non-small cell lung cancer (ICI-PREDICT study)

Shinkichi Takamori, Taro Ohba, [ ... ], Mitsuhiro Takenoyama

Do endocrine adverse events predict longer progression-free survival among patients with non-small-cell lung cancer receiving nivolumab?

Izabela Chmielewska, Marta Dudzińska, [ ... ], Agnieszka Zwolak

Immunohistochemical comparison of three programmed death-ligand 1 (PD-L1) assays in triple-negative breast cancer

Katsuhiro Yoshikawa, Mitsuaki Ishida, [ ... ], Tomoharu Sugie

Advertisement

Create a weekly email alert for: Immunotherapy

You can change these options by clicking profile then "Alerts and Notifications"